Patient‐Perceived Benefits of Named‐Patient Product Sublingual Immunotherapy in Allergic Rhinitis and Asthma: Primary Results From the <scp>ERAPP</scp> Real‐World Cohort Study
NPP-SLIT provides sustained, clinically meaningful benefit from the patient's perspective in both age groups. ERAPP supports the PBI as a complementary endpoint that links patient expectations to outcomes and informs patient-centered allergy care.
Authors
- R. Lassalle
- J. Cottet
- E. Bignon
- S. Lignot-Maleyran
- Abdelilah Abouelfath
- Davide Caimmi
- Pascal Demoly
- Patrick Blin
- Laure Carcaillon‐Bentata
- Evangéline Clark
Institutions
- Institut national de recherche en sciences et technologies du numérique (FR)
- Université de Bordeaux (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Bordeaux Population Health (FR)
- Les Hôpitaux de Chartres (FR)
- Montagu Hospital (GB)
- Hôpital Arnaud de Villeneuve (FR)
Publication Details
- Journal
- Allergy
- Published
- 2026-03-08
- DOI
- https://doi.org/10.1111/all.70270
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00